The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?

Vera M. Witjes,Marjolijn J.L. Ligtenberg,Janet R. Vos,Jozé C.C. Braspenning,Margreet G.E.M. Ausems,Marian J.E. Mourits,Joanne A. de Hullu,Eddy M.M. Adang,Nicoline Hoogerbrugge

Gynecologic Oncology（2023）

引用 1|浏览15

暂无评分

摘要

•An efficient strategy for genetic testing in epithelial ovarian cancer is highly desired.•We compared costs and effects of two strategies: Tumor-First and Germline-First.•Average testing costs per patient are much lower with the Tumor-First strategy.•In a likely scenario, more patients and relatives with a germline BRCA1/2 PV are identified with the Tumor-First strategy.

查看译文

关键词

Ovarian cancer,BRCA,Heredity,Cost analysis,Genetic testing

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要